Genome-wide association studies (GWAs) have led to the discovery of novel, robust associations for numerous complex diseases and phenotypes. While the new findings can be replicated reliably in other studies, the amount of phenotypic variation that is explained by the new association findings is small compared to the estimated total heritability of most diseases/traits. This suggests that the current GWAs are not able to identify most of the disease loci. Potential reasons are the study heterogeneity/confounding and the lack of sufficient statistical power to address the inherent multiple testing problem. For family-based designs, we will develop novel statistical methodology that achieves higher power levels than the currently used methodology and, at the same time, are completely robust again confounding. The application of the new methods to genome-wide association studies for Alzheimer's'Disease and Attention Deficit Hyperactivity Disorder will provide new insights that will help the scientific community to identify new genes for these diseases which are major public health problems in the United States.

Public Health Relevance

Alzheimer's disease and Attention Deficit Hyperactivity Disorder are major public health problems in the United States. The proposed statistical methodology will provide new analysis approaches that will enable researchers and clinicians to identify genetic risk loci for these diseases and other complex disease and phenotypes. In turn, an improved understanding of the genetic architecture of these conditions will result in a better and more efficient care for those who suffer from these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH087590-04
Application #
8392092
Study Section
Behavioral Genetics and Epidemiology Study Section (BGES)
Program Officer
Addington, Anjene M
Project Start
2009-12-01
Project End
2014-11-30
Budget Start
2012-12-01
Budget End
2014-11-30
Support Year
4
Fiscal Year
2013
Total Cost
$353,291
Indirect Cost
$72,246
Name
Harvard University
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Hecker, Julian; Prokopenko, Dmitry; Lange, Christoph et al. (2015) On the Recombination Rate Estimation in the Presence of Population Substructure. PLoS One 10:e0145152
Prokopenko, Dmitry; Hecker, Julian; Silverman, Edwin et al. (2015) Using Network Methodology to Infer Population Substructure. PLoS One 10:e0130708
Naylor, Melissa G; Cardenas, Valerie A; Tosun, Duygu et al. (2014) Voxelwise multivariate analysis of multimodality magnetic resonance imaging. Hum Brain Mapp 35:831-46
Erk, Susanne; Meyer-Lindenberg, Andreas; Schmierer, Phöbe et al. (2014) Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C. Biol Psychiatry 76:466-75
Erk, Susanne; Meyer-Lindenberg, Andreas; Linden, David E J et al. (2014) Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects. Neuroimage 94:147-54
Erk, S; Meyer-Lindenberg, A; Schmierer, P et al. (2013) Functional impact of a recently identified quantitative trait locus for hippocampal volume with genome-wide support. Transl Psychiatry 3:e287
Qiao, Dandi; Mattheisen, Manuel; Lange, Christoph (2013) On association analysis of rare variants under population substructure: an approach for the detection of subjects that can cause bias in the analysis--T opt: an outlier detection method. Genet Epidemiol 37:431-9
Fernandes, Carla P D; Christoforou, Andrea; Giddaluru, Sudheer et al. (2013) A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder. PLoS One 8:e81052
Adhikari, Kaustubh; AlChawa, Taofik; Ludwig, Kerstin et al. (2012) Is it rare or common? Genet Epidemiol 36:419-29
Mühleisen, Thomas W; Mattheisen, Manuel; Strohmaier, Jana et al. (2012) Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res 138:69-73

Showing the most recent 10 out of 27 publications